Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

SAINT ALPHONSUS MEDICAL CENTER NAMPA, INC.

NPI: 1659371870 · NAMPA, ID 83687 · Multi-Specialty Clinic/Center · NPI assigned 07/29/2005

$3.70M
Total Medicaid Paid
228,751
Total Claims
191,197
Beneficiaries
194
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialLEACH, TRAVIS (PRESIDENT)
Parent OrganizationTRINITY HEALTH OREGON-IDAHO INC
NPI Enumeration Date07/29/2005

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 61,211 $1.10M
2019 78,112 $1.48M
2020 49,420 $852K
2021 9,141 $90K
2022 10,380 $73K
2023 10,849 $65K
2024 9,638 $40K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
41899 Unlisted procedure, dentoalveolar structures 619 582 $1.14M
74177 Computed tomography, abdomen and pelvis; with contrast material 2,669 2,514 $340K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,753 2,691 $231K
80053 Comprehensive metabolic panel 21,026 16,240 $132K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 1,399 1,264 $103K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 22,108 16,848 $101K
99284 Emergency department visit for the evaluation and management, high severity 2,705 2,275 $95K
99283 Emergency department visit for the evaluation and management, moderate severity 2,202 1,892 $95K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 2,213 1,795 $91K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 1,357 1,264 $65K
70450 Computed tomography, head or brain; without contrast material 1,424 1,334 $58K
G0463 Hospital outpatient clinic visit for assessment and management of a patient 9,825 6,756 $55K
71275 Computed tomographic angiography, chest, with contrast material 438 420 $48K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 120 118 $47K
76705 Ultrasound, abdominal, real time with image documentation; limited 908 880 $38K
74176 Computed tomography, abdomen and pelvis; without contrast material 539 524 $37K
36415 Collection of venous blood by venipuncture 22,407 18,009 $36K
71046 Radiologic examination, chest; 2 views 2,615 2,502 $32K
87634 420 410 $32K
72125 Computed tomography, cervical spine; without contrast material 471 455 $29K
84484 5,559 3,881 $28K
77067 Screening mammography, bilateral, including computer-aided detection 662 655 $27K
84443 Thyroid stimulating hormone (TSH) 2,223 2,062 $26K
83690 5,145 4,533 $25K
72148 Magnetic resonance imaging, lumbar spine; without contrast material 302 296 $25K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 431 416 $23K
76830 Ultrasound, transvaginal 361 349 $22K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 603 592 $22K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 139 133 $21K
71045 Radiologic examination, chest; single view 4,481 3,996 $21K
J2469 Injection, palonosetron hcl, 25 mcg 173 104 $21K
96361 Intravenous infusion, hydration; each additional hour 1,423 1,165 $20K
76801 338 309 $19K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 495 480 $18K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 495 481 $18K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 566 540 $17K
71260 Computed tomography, thorax, diagnostic; with contrast material 275 265 $17K
87086 Culture, bacterial; quantitative colony count, urine 2,425 2,252 $16K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,555 1,967 $16K
81025 2,224 2,122 $15K
83880 943 863 $15K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal 311 284 $14K
81001 5,596 4,980 $13K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 262 256 $13K
84703 1,726 1,638 $13K
84702 756 638 $11K
J2785 Injection, regadenoson, 0.1 mg 138 132 $11K
83605 1,526 1,263 $11K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 796 783 $10K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 1,243 1,143 $10K
96375 Therapeutic injection; each additional sequential IV push 1,989 1,458 $10K
81003 5,123 4,720 $9K
84439 1,168 1,128 $8K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 390 380 $8K
J7120 Ringers lactate infusion, up to 1000 cc 2,566 2,348 $8K
87040 1,057 613 $8K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 850 620 $8K
J2704 Injection, propofol, 10 mg 2,132 2,023 $8K
87077 1,071 1,023 $8K
80061 Lipid panel 752 720 $7K
82248 1,567 1,471 $7K
70551 Magnetic resonance imaging, brain; without contrast material 78 77 $7K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 3,329 2,899 $6K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 191 133 $6K
83735 1,792 1,361 $6K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 142 140 $6K
87186 848 807 $6K
87400 251 247 $6K
80048 Basic metabolic panel (calcium, ionized) 1,063 875 $6K
76642 186 178 $6K
85379 707 687 $5K
J3010 Injection, fentanyl citrate, 0.1 mg 2,506 2,248 $5K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only 1,125 802 $5K
J2405 Injection, ondansetron hydrochloride, per 1 mg 6,233 5,418 $5K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 3,195 2,452 $5K
82550 1,211 1,092 $5K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,424 3,851 $5K
85610 2,141 1,793 $5K
85027 929 809 $5K
73610 304 297 $5K
83036 Hemoglobin; glycosylated (A1C) 760 739 $5K
87081 740 728 $5K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 161 138 $5K
J1170 Injection, hydromorphone, up to 4 mg 2,264 1,880 $5K
73630 349 334 $5K
82728 527 492 $5K
J2270 Injection, morphine sulfate, up to 10 mg 2,367 1,988 $4K
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) 20 13 $4K
73130 261 253 $4K
J0690 Injection, cefazolin sodium, 500 mg 974 862 $4K
87486 120 118 $4K
87581 120 118 $4K
86140 982 883 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg 1,843 1,692 $4K
87280 272 270 $4K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 830 234 $4K
85730 853 793 $4K
87210 695 354 $3K
84466 426 398 $3K
74018 251 238 $3K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 1,246 889 $3K
86003 29 28 $3K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited 72 65 $3K
82553 452 428 $3K
J0780 Injection, prochlorperazine, up to 10 mg 380 351 $3K
73110 152 144 $3K
80306 198 187 $3K
90715 108 107 $2K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 489 287 $2K
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose 40 38 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg 1,108 725 $2K
82803 152 136 $2K
73562 143 137 $2K
97162 56 55 $2K
87070 265 249 $2K
86901 689 602 $2K
73030 163 156 $2K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences 16 15 $2K
86900 670 602 $2K
83540 436 407 $2K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose 39 36 $2K
99282 Emergency department visit for the evaluation and management, low to moderate severity 72 66 $2K
85652 873 780 $2K
72100 98 95 $1K
82607 126 118 $1K
J2550 Injection, promethazine hcl, up to 50 mg 652 558 $1K
74220 27 27 $1K
J2795 Injection, ropivacaine hydrochloride, 1 mg 91 86 $1K
J1200 Injection, diphenhydramine hcl, up to 50 mg 1,437 1,184 $1K
86850 185 169 $1K
83615 223 197 $972.38
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material 13 12 $964.81
76700 Ultrasound, abdominal, real time with image documentation; complete 15 15 $955.64
J7050 Infusion, normal saline solution, 250 cc 949 451 $896.42
J2765 Injection, metoclopramide hcl, up to 10 mg 644 576 $885.48
J0330 Injection, succinylcholine chloride, up to 20 mg 235 223 $881.14
82150 142 137 $865.21
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 212 196 $827.77
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 13 12 $816.23
A9575 Injection, gadoterate meglumine, 0.1 ml 124 121 $765.68
P9612 Catheterization for collection of specimen, single patient, all places of service 363 353 $738.42
76536 12 12 $735.20
82570 176 152 $712.66
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 179 158 $709.44
87205 213 193 $664.35
84100 235 201 $633.65
71250 32 30 $607.52
76770 12 12 $585.77
93016 37 36 $582.01
73080 42 42 $579.62
81002 215 198 $563.47
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) 753 604 $485.39
97166 15 13 $473.07
82785 29 27 $457.23
J2060 Injection, lorazepam, 2 mg 723 643 $426.53
73090 30 30 $394.09
77080 41 41 $392.55
J7030 Infusion, normal saline solution , 1000 cc 1,181 755 $372.01
93018 37 36 $334.88
J0171 Injection, adrenalin, epinephrine, 0.1 mg 44 40 $303.60
J1815 Injection, insulin, per 5 units 105 53 $303.20
82746 26 24 $300.95
J1630 Injection, haloperidol, up to 5 mg 286 232 $271.85
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 108 71 $267.68
82378 18 17 $203.85
84156 51 43 $191.76
J8540 Dexamethasone, oral, 0.25 mg 93 83 $191.37
73502 13 12 $189.42
G0008 Administration of influenza virus vaccine 32 29 $160.89
82390 12 12 $137.23
J8597 Antiemetic drug, oral, not otherwise specified 1,373 1,330 $135.58
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 1,252 1,164 $132.36
82247 21 12 $116.97
82565 24 24 $108.72
84550 29 25 $104.39
73590 12 12 $102.95
J3475 Injection, magnesium sulfate, per 500 mg 40 26 $101.53
J3370 Injection, vancomycin hcl, 500 mg 12 12 $94.68
A9585 Injection, gadobutrol, 0.1 ml 100 98 $78.96
90686 16 15 $68.41
96376 19 12 $64.98
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 160 139 $63.95
93017 13 13 $43.05
36416 14 12 $39.00
77063 Screening digital breast tomosynthesis, bilateral 603 596 $20.64
J3480 Injection, potassium chloride, per 2 meq 19 13 $17.05
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 59 52 $14.93
97802 50 50 $0.00
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) 21 12 $0.00
G8980 Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting 28 25 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 106 102 $0.00
88305 Level IV - Surgical pathology, gross and microscopic examination 13 13 $0.00
G8978 Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals 40 37 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 55 38 $0.00